Novlead Biotech

Novlead Biotech is a verified Series B medical device company (approx. 130 employees, ~$18M+ funding) developing Nitric Oxide therapy solutions. While the project has high real-world utility and verified traction (CE certification progress, strong team), the submission itself contained exaggerated and lazy claims (e.g., 'most people have used my product', audience 'everyone'), which negatively impacted the Response Quality and Audience Reach scores. The final score reflects the legitimate high value and scale of the business, adjusted for the uncertainty introduced by the poor submission quality.